Acta dermato-venereologica
-
Acta Derm. Venereol. · Mar 1995
Randomized Controlled Trial Multicenter Study Clinical TrialEfficacy of cetirizine in cholinergic urticaria.
In order to examine the efficacy of cetirizine in cholinergic urticaria, we studied 24 patients in a double-blind crossover design during 3-week treatment periods, with either 10 or 20 mg/d cetirizine or placebo. The placebo period was always placed in between the two verum treatments to allow for a washout of the drug. ⋯ Except for whealing (p < 0.05), no significant differences between the two dosages of cetirizine could be determined. Since antihistamines have previously been shown to be frequently unsatisfactory in the treatment of cholinergic urticaria, the present data are encouraging regarding the control of symptoms in this condition.
-
Acta Derm. Venereol. · Jun 1993
Randomized Controlled Trial Clinical TrialRepeated treatment with lidocaine/prilocaine cream (EMLA) as a topical anaesthetic for the cleansing of venous leg ulcers. A controlled study.
Repeated topical analgesia with EMLA 5% cream prior to the cleansing of venous leg ulcers was studied. Patients were randomly allocated to a series of 8 treatments with EMLA (n = 22) or to a control group (n = 21). A thick layer of the cream was applied to the ulcers for 30 min. ⋯ The analgesic effect remained unchanged with successive treatments. Repeated treatment with EMLA in leg ulcers would appear to be safe, as indicated by the absence of any serious untoward events. No statistically significant differences in local reactions or adverse effects on granulation tissue, ulcer area or bacterial flora were observed in the EMLA-treated patients compared with the control patients.
-
Acta Derm. Venereol. · Jan 1990
Randomized Controlled Trial Clinical TrialPain control in the surgical debridement of leg ulcers by the use of a topical lidocaine--prilocaine cream, EMLA.
The analgesic effect of EMLA 5% cream for surgical cleansing of leg ulcers was investigated in an open study and in a double-blind comparison with placebo. Eighty patients with ulcers of venous or arterial origin participated. The cream was applied under occlusion and removed before cleansing. ⋯ The median VAS pain scores for EMLA and placebo were 18.5 and 84 mm (p less than 0.01). There were no severe adverse reactions. The results show that there is a need for pain control in surgical debridement of leg ulcers and that EMLA cream gives satisfactory analgesia for this procedure.
-
Acta Derm. Venereol. · Jan 1970
Randomized Controlled Trial Comparative Study Clinical Trial Controlled Clinical TrialClinical evaluation of bendazac (AF-983). A non-steroid topical anti-inflammatory agent.